Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in BAP1 GeneAzam Ghafoor, Raffit Hassan, Jun S. Wei et al.|JTO Clinical and Research Reports|2021Cited by 57
Phase II study of olaparib in malignant mesothelioma (MM) to correlate efficacy with germline and somatic mutations in DNA repair genes.Raffit Hassan, Azam Ghafoor, Idrees Mian et al.|Journal of Clinical Oncology|2020Cited by 22
Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 MutationsZishuo I. Hu, Azam Ghafoor, Raffit Hassan et al.|Journal of Thoracic Oncology|2021Cited by 7